Partner Content Partner Content STORM Therapeutics Joins SMi’s 9th Annual RNA Therapeutics STORM Therapeutics Exclusive Speaker Interview
Partner Content Partner Content STORM Therapeutics Announces Publication in Nature on RNA Ep... RNA Therapeutics
News Orchard's gene therapy for MLD finally gets US approval The FDA has cleared its first gene therapy for kids with metachromatic leukodystrophy (MLD), a rare genetic disorder of the brain and nervous centre.
Sales & Marketing Sponsored Take pharma brand planning to the next level in 2024 Today, pharma brand planning teams can benefit from technology platforms that aggregate data and automate analyses, helping unlock insights on the market landscape and clinical environment